News & Events:SDGR

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the appointment of Arun Oberoi to its Board of Directors, effective May 17, 2022. This press release features multimedia. “We are very pleased to welcome Arun to our Board,” said Ramy Farid, Ph.D., president and chief executive officer of Schrödinger.

Schrödinger, whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate at the Citi Biotech Virtual Co-Panel Day.

Schrodinger Inc (SDGR): * SCHRÖDINGER REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS. * COMPANY MAINTAINS FULL-YEAR 2022 FINANCIAL OUTLOOK. * QTRLY TOTAL REVENUE$48.7 MILLION VERSUS $32.1 MILLION. * IND SUBMISSION FOR SGR-1505, SCHRÖDINGER'S MALT1 INHIBITOR, ON-TRACK FOR FIRST HALF OF 2022.

Software Revenue of $33.1 Million, a 26 Percent Increase Over First Quarter of 2021; Total Revenue of $48.7 Million, up 51 Percent Over First Quarter of 2021 Company Maintains Full-Year 2022 Financial Outlook Internal Pipeline Progressing, With IND Submission for SGR-1505, Schrödinger’s MALT1 Inhibitor, On-Track for First Half of 2022 NEW YORK---- Schrödinger, Inc., whose physics-based soft...

Schrödinger, whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2022 financial results on Wednesday, May 4, 2022, after the financial markets close. The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar.

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2022, the company granted non-statutory stock options to purchase an aggregate of 101,715 shares of the company’s common stock to 30 newly hired employees, including six newly hired employees based in India and one newly hired employee base...

SHANGHAI, April 12, 2022 /PRNewswire/ – Forbes released the 2022 Midas List on April 12, a ranking of the world's top 100 venture capitalists. Since 2001, Forbes announces its annual Midas List of the top VC investors in the world. Nisa has been on the list for four consecutive years, ranking No.61 and up 12 places from last year.

Schrodinger Inc (SDGR): * SCHRÖDINGER REPORTS NEW PRECLINICAL DATA SUPPORTING ADVANCEMENT OF ITS WEE1 INHIBITOR PROGRAM AT AMERICAN ASSOCIATION OF CANCER RESEARCH 2022 ANNUAL MEETING. * Schrodinger Inc (SDGR) - HIGHLY SELECTIVE AND STRUCTURALLY-DISTINCT WEE1 INHIBITORS DEMONSTRATE STRONG ANTI-TUMOR ACTIVITY IN TUMOR MODELS.

Schrödinger’s Highly Selective and Structurally-Distinct Wee1 Inhibitors Demonstrate Strong Anti-Tumor Activity in Tumor Models On Track to Select a Wee1 Development Candidate in 2022 Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today presented new preclinical data from its Wee1 inhibitor program in a poster session ...

SHANGHAI, March 29, 2022 Qiming Venture Partners' portfolio company Rendu Biotechnology, a leader in RNA molecular diagnostics in China, today listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. Qiming Venture Partners is the earliest investor in Rendu Biotechnology and led the company's Series A financing round in 2013.

SHANGHAI, March 22, 2022  Qiming Venture Partners' portfolio company Arrail Group, a leading dental services provider in China, today listed on the main board of Hong Kong Stock Exchange. As an early investor, Qiming Venture Partners first invested in Arrail Group in 2010 and followed on in the company's Series A, B and C rounds.

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2022, the company granted non-statutory stock options to purchase an aggregate of 42,425 shares of the company’s common stock to 17 newly hired employees, including seven newly hired employees based in India.

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that new preclinical data on its small-molecule Wee1 inhibitors will be presented during a poster session at the American Association of Cancer Research Annual Meeting taking place in New Orleans, Louisiana, April 8-13, 2022.

SHANGHAI, March 1, 2022 Qiming Venture Partners, a leading venture capital firm in China, is pleased to announce that David Chu has joined the firm as a Partner, focusing on fundraising and investor relations for Qiming's USD funds. David has extensive experience in fund management and investment.

Schrödinger, whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate at the Truist Securities Life Sciences AI Symposium - Biotech & Tools.

Schrodinger Inc (SDGR): * SCHRÖDINGER REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2021. * SEES FY REVENUE UP 17 TO 31 PERCENT. * SEES FY REVENUE $161 MILLION TO $181 MILLION. * QTRLY TOTAL REVENUE $46.2 MILLION VERSUS $33 MILLION. * SEES ONGOING GROWTH IN ADOPTION AND SCALE UP OF SOFTWARE PLATFORM, WITH TARGET ACV GROWTH OF OVER 20 PERCENT IN 2023.

Delivered Strong Fourth Quarter, with Software Revenue of $38.6 Million, a 55 Percent Increase over Fourth Quarter of 2020 Full Year 2021 Total Revenue of $137.9 Million, up 28 Percent Year-over-Year, with Full Year 2021 Software Revenue of $113.2 Million, up 22 Percent Year-over-Year Provides Financial Outlook for 2022 and Outlines Key Strategic Goals for 2022-2023 NEW YORK---- Schrödinger, In...